Matches 1 - 50 out of 89 1 2 >
Match Document Document Title
7589083 Compounds and compositions to control abnormal cell growth  
A class of compounds commonly containing a trialkylammonium group have been synthesized and characterized as anticancer compounds. A representative of this class,...
7576094 Spiro derivatives as lipoxygenase inhibitors  
The present invention is concerned with certain novel spiro substituted heterocylic ring derivatives. These compounds may be useful in the manufacture of pharmaceutical compositions for treating...
7482344 Tricyclic steroid hormone nuclear receptor modulators  
The present invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising an effective amount of a compound of Formula I in...
7423029 Compounds to promote regeneration of bone marrow  
Embodiments of the present invention include the use of heterocyclic trialkyl ammonium-containing compounds to promote regeneration of bone marrow from endogenous or exogenous stem/progenitor cells...
7288560 Spirocyclic cyclohexane derivatives  
The present invention relates to spirocyclic cyclohexane compounds, to methods for their production, to pharmaceutical compositions containing these compounds, to methods of treatment using such...
7268148 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes  
Acne-affected skin has been found to be accompanied by the presence of matrix-degrading enzymes such as MMPs and neutrophil elastase, induction of neutrophils, and a reduction in procollagen...
7238725 Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them  
The present invention relates to novel tricyclic compounds useful for the treatment of inflammatory conditions, diseases of the central nervous and insulin resistant diabetes.
7223774 Benzamide 2-hydroxy-3-diaminoalkanes  
The present invention relates to compounds of formula (I): useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme...
7115605 Peptide deformylase inhibitors  
PDF inhibitors and novel methods for their use are provided.
7105569 Fungicidal active compound combinations  
New active compound combinations of valinamide derivatives of the formula (I) in which R 1 and R 2 has the meaning given in the description, with known fungicidal active substances,...
7019024 Pharmaceutical for treatment of neurological and neuropsychiatric disorders  
The invention provides a pharmaceutical for treatment of neurological and neuropsychiatric disorders comprising a compound of the formula: or a pharmaceutically acceptable salt thereof.
6825226 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias  
The invention relates to the discovery that specific adamantyl or adamantyl group derivatives containing retinoid-related compounds induce apoptosis of cancer cells and therefore may be used for...
6806283 Selective serotonin receptor antagonists and therapeutic applications thereof  
Spiro[9,10-dihydroanthracene]-9,3′-pyrrolidine (SPAN) and derivatives thereof are provided as selective serotonin receptor antagonists. The compounds are selective, high affinity antagonists of...
6784202 Cubane derivatives as metabotropic glutamate receptor agonists or antagonists and process for their preparation  
The present invention relates to therapeutically active cubane compounds, a method of preparing the same, and to pharmaceutical compositions comprising the compounds. The novel compounds are useful...
6767919 High specificity anticancer agents  
A process for producing new anticancer drugs such that the drugs can be administered in a nontoxic, proto-drug form and, subsequent to a time delay which allows for differential concentration in...
6730697 Dihydrothiaphenanthrenecarbonylguanidines: composition, process of making, and use as medicament or diagnostic aid  
Dihydrothiaphenanthrenecarbonylguanidine compound of formula I These compounds are potentially suitable as antiarrythmic medicaments with a cardioprotective component for prophylaxis of an...
6693136 Fluorenes and anthracenes that inhibit P2X3 and P2X2/3 containing receptors  
Compounds of formula (I) are novel P2X 3 and P2X 2 /P2X 3 containing receptor antagonists and are useful in treating pain, urinary incontinence, and bladder overactivity.
6620834 Medicinal compositions for treating colorectal cancer  
Medicinal compositions for colorectal cancer to be administered to the large intestine by taking advantage of preparations disintegrating in the large intestine, characterized by containing a...
6613797 Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins  
Therapeutic compounds and compositions for the treatment of infectious diseases are disclosed. The compounds are xanthones and xanthone derivatives, such as...
6602903 Substituted heterocyclic compounds  
The invention relates to compounds of formula (I): and medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
6566389 Therapeutic uses of melatonin  
A method for treating or preventing symptoms of tardive dyskensia comprises administering melatonin to patient exhibiting or liable to develop such symptoms. The melatonin is administered in an...
6521641 Male anti-fertility agents  
Methods and compositions for inhibiting or preventing spermatogenesis in a male mammal. Also disclosed are compounds and formulations for use in such methods.
6514967 Compound for preparing medicines for treating pathologies involving extracellular glutamate, and methods for obtaining same  
The invention relates to compounds of the following general formula (I): in which: R 1 and R 2 represent a hydrogen atom, or form a ring, especially a benzene ring, R 3 represents a hydrogen...
6511968 Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions  
The invention provides a method for treating, preventing, or reducing the risk of developing a condition selected from the group consisting of acute coronary ischemic syndrome, thrombosis,...
6391911 Coadministration of lucanthone and radiation for treatment of cancer  
Disclosed is a method of treating a cancer of the central nervous system in a host including administering radiation to the host; and administering lucanthone to the host; wherein the radiation and...
6384045 Tricyclic and tetracyclic pyrones  
This invention provides cancer-active tricyclic and tetracyclic oxypyrones and a method of synthesizing these compounds. Preferred compounds have aryl groups at the 3-position of the oxypyrone...
6258836 Dopamine analog amide  
The invention involves the formation of a prodrug from a fatty acid carrier and a neuroactive drug. The prodrug is stable in the environment of both the stomach and the bloodstream and may be...
6245797 Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease  
The instant invention provides a drug combination comprised of an HMG-CoA reductase inhibitor in combination with a COX-2 inhibitor, which is useful for treating, preventing, and/or reducing the...
6172058 Compounds with pharmaceutical properties  
A pharmaceutical compound of the formula ##STR1## in which R 1 is C 1 -10 alkyl, C 2 -10 alkenyl, C 2 -10 alkynyl, C 3 -10 cycloalkyl, C 3 -10 cycloalkyl-C 1 -10 alkyl, C 3 -10 cycloalkyl-C 2 -10...
6117869 Compounds for and methods of inhibiting matrix metalloproteinases  
The present invention relates to compounds of Formula I that inhibit matrix metalloproteinases and to a method of inhibiting matrix metalloproteinases using the compounds ##STR1## More...
6100253 Tricycle substituted with azaheterocyclic carboxylic acids  
The present invention relates to novel N-substituted azaheterocyclic compounds of the general formula ##STR1## wherein X, Y, Z, R 1 , R 2 and r are as defined in the detailed part of the present...
6054448 2-amino-2-(3-substituted cyclobutyl) acetic acid derivatives  
Compounds of the formula ##STR1## in which R 1 is Y or Y--C 1 -6 alkyl, where Y is carboxy, tetrazolyl, --SO 2 H, --SO 3 H, --OSO 3 H, --CONHOH, or --P(OH)OR', --PO(OH)OR', --OP(OH)OR' or...
5994392 Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid  
The invention involves the formation of a prodrug from a fatty acid carrier and a neuroactive drug. The prodrug is stable in the environment of both the stomach and the bloodstream and may be...
5990104 Polycyclic alcaloid-derivatives as NMDA-receptor antagonists  
Polycyclic alkaloids of formula (I), wherein R 1 is H, C 1 -6 alkyl, or C 6 -12 aryl optionally substituted with polar groups; R 2 and R 3 are independently H, OH, C 1 -6 alkyl, --C(NH)--NH 2 ,...
5977077 Xanthone analogs for the treatment of infectious diseases  
Therapeutic compositions for the treatment of infectious diseases are disclosed. These compositions comprise xanthones and xanthone derivatives, such as 2,3,4,5,6-pentahydroxyxanthone. Also...
5891899 Pharmaceutical xanthene compounds  
A pharmaceutical compound of the formula: ##STR1## in which A is carboxy, tetrazolyl, --SO 2 H, --SO 3 H, --OSO 3 H, --CONHOH, or --P(OH)OR', --PO(OH)OR', --OPO(OH)OR' B is a bond, C 1 -6...
5880146 Inhibition of IL-12-induced IFN-γ synthesis by specific bis-phenol compounds as a method of immune modulation  
Disclosed are chemical agents for modulating certain cellular immune reactions that can lead to autoimmune disorders. By specific modulation, harmful immune reactions can be lessened in severity or...
5827856 Method of treating insulin resistance  
The present invention provides a novel method for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting...
5726208 Heterocyclic tertiary amines  
New compounds of formula: ##STR1## wherein: --A--D--E, X, n, Y and Z are as defined in the description, in racemic form and in the form of optical isomers, and their addition salts with...
5665760 Lyophilized thioxanthenone antitumor agents  
Disclosed are reconstituted lyophilized formulations for the treatment of mammalian tumors comprising a thioxanthenone antitumor agent in combination with mannitol or sucrose as a stabilizer in a...
5571825 Method of selectively inhibiting prostaglandin G/H synthase-2  
The present invention provides a method of selectively inhibiting prostaglandin G/H synthase-2 that comprises administering to a patient in need of such inhibition an inhibiting amount of a...
5550110 Endothelin Antagonists II  
Novel antagonists of endothelin are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, acute...
5447960 Fungicidal use of phenolic aromatic compounds  
A plant fungicide method comprises applying to the locus of a plant pathogen a fungicidally effective amount of a compound of formula (I) ##STR1## or a salt or a complex thereof, wherein: R 1 , R 2...
5438056 Heterocyclic oxime carbamates  
The compounds of the present invention have the following formula: ##STR1## wherein R 1 and R 2 are independently phenyl, pyridyl, thienyl, naphthyl, substituted phenyl wherein the substituent is...
5380749 Thioxanthenone antitumor agents  
1-[[(Dialkylamino)alkyl]amino]-4-substituted-thioxanthen-9-o nes are disclosed as antitumor agents. Compositions containing the thioxanthenones and methods of treating tumors and cancer in mammals...
5276053 Polycyclic amines useful as cerebrovascular agents  
A novel series of polycyclic amines, derivatives, methods of making the compounds, novel intermediates, compositions containing them, and methods for using them in the treatment and prevention of...
5196445 Heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases  
Heteroaryl-3-oxo-propanenitrile derivatives of formula (I) ##STR1## wherein X represents an oxygen atom or a --CH(R 4 )--, --O--CH(R 4 )--, --S(O) n --CH(R 4 )--, --CH(R 4 )--O--, --CH(R 4 )--S(O)...
5192765 Certain amines which are muscarinic receptor antagonists  
Amines of the following formula: ##STR1## where the variables are defined in the specification are useful in the treatment of diseases associated with altered motility and/or tone of smooth muscle.
5104858 Sensitizing multidrug resistant cells to antitumor agents  
A method for sensitizing multidrug resistant cells to antitumor agents comprosing contacting multidrug resistant cells, with an effective amount of a compound of the formula ##STR1## wherein n is...
5071853 Polycyclic amines useful as cerebrovascular agents  
A novel series of polycyclic amines, derivatives, methods of making the compounds, novel intermediates, compositions containing them, and methods for using them in the treatment and prevention of...
Matches 1 - 50 out of 89 1 2 >